annual CFI:
-$258.02M-$216.83M(-526.36%)Summary
- As of today (June 17, 2025), JANX annual cash flow from investing activities is -$258.02 million, with the most recent change of -$216.83 million (-526.36%) on December 31, 2024.
- During the last 3 years, JANX annual CFI has risen by +$82.94 million (+24.33%).
- JANX annual CFI is now -542.83% below its all-time high of $58.27 million, reached on December 31, 2022.
Performance
JANX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$340.39M-$374.32M(-1103.34%)Summary
- As of today (June 17, 2025), JANX quarterly cash flow from investing activities is -$340.39 million, with the most recent change of -$374.32 million (-1103.34%) on March 31, 2025.
- Over the past year, JANX quarterly CFI has dropped by -$226.66 million (-199.28%).
- JANX quarterly CFI is now -1103.34% below its all-time high of $33.93 million, reached on December 31, 2024.
Performance
JANX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$484.68M-$226.66M(-87.84%)Summary
- As of today (June 17, 2025), JANX TTM cash flow from investing activities is -$484.68 million, with the most recent change of -$226.66 million (-87.84%) on March 31, 2025.
- Over the past year, JANX TTM CFI has dropped by -$338.49 million (-231.54%).
- JANX TTM CFI is now -821.29% below its all-time high of $67.20 million, reached on September 30, 2022.
Performance
JANX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
JANX Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -526.4% | -199.3% | -231.5% |
| 3 y3 years | +24.3% | -1195.6% | -56.5% |
| 5 y5 years | -100.0% | -100.0% | -100.0% |
JANX Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -542.8% | +24.3% | -1103.3% | at low | -821.3% | at low |
| 5 y | 5-year | -542.8% | +24.3% | -1103.3% | at low | -821.3% | at low |
| alltime | all time | -542.8% | +24.3% | -1103.3% | at low | -821.3% | at low |
JANX Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$340.39M(-1103.3%) | -$484.68M(+87.8%) |
| Dec 2024 | -$258.02M(+526.4%) | $33.93M(+167.7%) | -$258.02M(-8.1%) |
| Sep 2024 | - | $12.67M(-106.6%) | -$280.82M(-20.9%) |
| Jun 2024 | - | -$190.88M(+67.8%) | -$354.95M(+142.8%) |
| Mar 2024 | - | -$113.74M(-1122.5%) | -$146.19M(+254.9%) |
| Dec 2023 | -$41.19M(-170.7%) | $11.12M(-118.1%) | -$41.19M(-23.6%) |
| Sep 2023 | - | -$61.45M(-443.8%) | -$53.92M(-297.6%) |
| Jun 2023 | - | $17.87M(-304.5%) | $27.29M(+47.9%) |
| Mar 2023 | - | -$8.74M(+444.9%) | $18.46M(-68.3%) |
| Dec 2022 | $58.27M | -$1.60M(-108.1%) | $58.27M(-13.3%) |
| Sep 2022 | - | $19.76M(+118.6%) | $67.20M(-142.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $9.04M(-70.9%) | -$158.11M(-49.0%) |
| Mar 2022 | - | $31.07M(+324.1%) | -$309.74M(-9.2%) |
| Dec 2021 | -$340.96M(<-9900.0%) | $7.33M(-103.6%) | -$340.96M(-2.1%) |
| Sep 2021 | - | -$205.54M(+44.1%) | -$348.29M(+144.0%) |
| Jun 2021 | - | -$142.60M(>+9900.0%) | -$142.75M(>+9900.0%) |
| Mar 2021 | - | -$153.00K(<-9900.0%) | -$153.00K(<-9900.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Janux Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Janux Therapeutics?
- What is Janux Therapeutics annual CFI year-on-year change?
- What is Janux Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Janux Therapeutics?
- What is Janux Therapeutics quarterly CFI year-on-year change?
- What is Janux Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Janux Therapeutics?
- What is Janux Therapeutics TTM CFI year-on-year change?
What is Janux Therapeutics annual cash flow from investing activities?
The current annual CFI of JANX is -$258.02M
What is the all time high annual CFI for Janux Therapeutics?
Janux Therapeutics all-time high annual cash flow from investing activities is $58.27M
What is Janux Therapeutics annual CFI year-on-year change?
Over the past year, JANX annual cash flow from investing activities has changed by -$216.83M (-526.36%)
What is Janux Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of JANX is -$340.39M
What is the all time high quarterly CFI for Janux Therapeutics?
Janux Therapeutics all-time high quarterly cash flow from investing activities is $33.93M
What is Janux Therapeutics quarterly CFI year-on-year change?
Over the past year, JANX quarterly cash flow from investing activities has changed by -$226.66M (-199.28%)
What is Janux Therapeutics TTM cash flow from investing activities?
The current TTM CFI of JANX is -$484.68M
What is the all time high TTM CFI for Janux Therapeutics?
Janux Therapeutics all-time high TTM cash flow from investing activities is $67.20M
What is Janux Therapeutics TTM CFI year-on-year change?
Over the past year, JANX TTM cash flow from investing activities has changed by -$338.49M (-231.54%)